z-logo
Premium
Adenoma‐carcinoma sequence: A reappraisal with immunohistochemical expression of ferritin
Author(s) -
Yang HsiaoBai,
Hsu PingI,
Lee JenChang,
Chan ShihHuang,
Lin XiZhang,
Chow NanHaw
Publication year - 1995
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930600108
Subject(s) - adenoma , immunohistochemistry , pathology , medicine , dysplasia , adenocarcinoma , carcinoma , colorectal cancer , tubular adenoma , cancer , ferritin , colonoscopy
To examine the biological significance of ferritin (FRN) expression, a retrospective immunohistochemical study was performed in normal coIonic mucosae (n = 8), adenomas (n = 88), and colorectal carcinomas (n = 104). FRN was present in some epithelia in the crypt base of normal colonic mucosae. Significant cytoplasmic staining for FRN was revealed in 26 (29.5%) cases of adenoma and 54 cases (51.9%) of adenocarcinoma. The cancer cells had a higher proportion of FRN expression than those of adenomas or non‐neoplastic mucosae ( P < 0.001). Expression of FRN showed a positive association with the degree of dysplasia ( P = 0.039) and the distal location of adenoma ( P = 0.013). FRN expression tended to be associated with the tumor size ( P = 0.083), but no substantial difference was observed among the histologic types of adenoma ( P = 0.754). The results suggest that cytoplasmic FRN expression is associated with cellular proliferation. The proliferative index shows a significant difference through the adenoma‐carcinoma sequence. Further investigation is necessary to clarify the clinical implication of FRN expression in tumor cells and normal‐appearing mucosae. © 1995 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom